| NDC Code | 72960-112-02 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE |
|---|
| Product NDC | 72960-112 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Daxxify |
|---|
| Non-Proprietary Name | Botulinum Toxin Type A |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20220920 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761127 |
|---|
| Manufacturer | Revance Therapeutics, Inc. |
|---|
| Substance Name | BOTULINUM TOXIN TYPE A |
|---|
| Strength | 100 |
|---|
| Strength Unit | U/1.2mL |
|---|
| Pharmacy Classes | Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC] |
|---|